A phase I study of the vitamin D analogue EB 1089 in patients with advanced breast and colorectal cancer

Title: A phase I study of the vitamin D analogue EB 1089 in patients with advanced breast and colorectal cancer
Author(s): Gulliford, T
English, J
Colston, KW
Menday, P
Moller, S
Coombes, RC
Item Type: Journal Article
Publication Date: 1-Jul-1998
URI: http://hdl.handle.net/10044/1/53542
DOI: https://dx.doi.org/10.1038/bjc.1998.434
ISSN: 0007-0920
Publisher: CHURCHILL LIVINGSTONE
Start Page: 6
End Page: 13
Journal / Book Title: BRITISH JOURNAL OF CANCER
Volume: 78
Issue: 1
Copyright Statement: Creative Commons Attribution Non-Commercial Share Alike License
Keywords: Science & Technology
Life Sciences & Biomedicine
Oncology
ONCOLOGY
calcitriol
cancer therapy
differentiation agents
LEUKEMIC-CELL GROWTH
1,25-DIHYDROXYVITAMIN-D3
DIFFERENTIATION
INVIVO
1-ALPHA,25-DIHYDROXYVITAMIN-D3
CALCIPOTRIOL
COMBINATION
INHIBITION
PSORIASIS
HORMONE
Adult
Aged
Antineoplastic Agents
Breast Neoplasms
Calcitriol
Calcium, Dietary
Colonic Neoplasms
Dose-Response Relationship, Drug
Female
Humans
Hypercalcemia
Male
Middle Aged
Humans
Breast Neoplasms
Colonic Neoplasms
Hypercalcemia
Calcium, Dietary
Calcitriol
Antineoplastic Agents
Dose-Response Relationship, Drug
Adult
Aged
Middle Aged
Female
Male
1112 Oncology And Carcinogenesis
Oncology & Carcinogenesis
Publication Status: Published
Appears in Collections:Division of Surgery
Division of Cancer
Faculty of Medicine



Items in Spiral are protected by copyright, with all rights reserved, unless otherwise indicated.

Creative Commons